Home » Topics » Regulatory

Regulatory
RSS

Oral vitamin D prohormone cleared by the FDA for secondary hyperparathyroidism

June 11, 1999

ATTRACT trial demonstrates long-term efficacy and safety of Remicade in RA

June 11, 1999

Antidiabetic compound effectively treats obesity in patients with altered glucose metabolism

June 11, 1999

FDA advisory committee recommends approval of Doxil sNDA

June 10, 1999

ODAC recommends approval of Ethyol for dry mouth

June 10, 1999

Widely used antipsychotic drug under study for potential in RA

June 9, 1999

New use for an old drug: doxycycline in the treatment of abdominal aortic aneurysms

June 9, 1999

Valaciclovir reduces CMV in kidney transplant recipients

June 9, 1999

European Commission issues first approval for tasonermin

June 8, 1999

Fujisawa works to expand the clinical indications of tacrolimus

June 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.